zintick

Medpace MEDP

Medpace Holdings, Inc. · Nasdaq · Services-Commercial Physical & Biological Research

$692.68+2.80%close on Oct. 28, 2026 · volume 301K · Yahoo Finance

Price, last 47 sessions

$600.00$650.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $692.68 · low $583.16 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Oct. 27, 2026Susan E. Burwig
Exec. VP, Operations
Sold3,940$677.00$2.67 million
Oct. 26, 2026Susan E. Burwig
Exec. VP, Operations
Sold16,060$677.00$10.87 million
Sept. 30, 2026August J. Troendle
President & CEO, director, 10% owner
Sold21,966$625.47$13.74 million
Sept. 29, 2026August J. Troendle
President & CEO, director, 10% owner
Sold26,701$621.02$16.58 million
Sept. 28, 2026August J. Troendle
President & CEO, director, 10% owner
Sold2,410$620.07$1.49 million
Sept. 25, 2026August J. Troendle
President & CEO, director, 10% owner
Sold154$620.60$95,572
Sept. 24, 2026August J. Troendle
President & CEO, director, 10% owner
Sold27,833$621.33$17.29 million
Sept. 23, 2026August J. Troendle
President & CEO, director, 10% owner
Sold16,083$628.64$10.11 million
Sept. 22, 2026August J. Troendle
President & CEO, director, 10% owner
Sold49,018$628.11$30.79 million
Sept. 21, 2026August J. Troendle
President & CEO, director, 10% owner
Sold21,883$623.29$13.64 million
Sept. 17, 2026August J. Troendle
President & CEO, director, 10% owner
Sold10,880$620.40$6.75 million
Sept. 16, 2026August J. Troendle
President & CEO, director, 10% owner
Sold8,770$621.29$5.45 million

Latest 12 of 33. Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 32 →
  • 4Oct. 28, 2026, 4:23 p.m. ETView on SEC.gov
  • 4Oct. 23, 2026, 4:11 p.m. ETView on SEC.gov
  • 10-QOct. 22, 2026, 4:02 p.m. ETView on SEC.gov
  • 8-KOct. 21, 2026, 4:15 p.m. ETView on SEC.gov

    Results of operations and financial condition · Other events · Financial statements and exhibits

    AI summary, unreviewedMedpace Holdings (MEDP) Q3 2026 Revenue Rises 8.5% to $716.0 Million, Diluted EPS $4.84 vs $3.86; Guidance Given; $1.0 Billion Buyback Authorized

  • 4Oct. 14, 2026, 4:14 p.m. ETView on SEC.gov
  • 4Oct. 9, 2026, 4:14 p.m. ETView on SEC.gov
  • 4Oct. 2, 2026, 5:19 p.m. ETView on SEC.gov
  • 4Oct. 2, 2026, 5:11 p.m. ETView on SEC.gov